How long has tirzepatide been around?

How long has tirzepatide been around (first approval and availability)?

Tirzepatide has been publicly available since 2022, when the U.S. FDA approved it for diabetes and weight loss in the brand-name medicines Mounjaro and Zepbound. [1][2]

When did tirzepatide first get FDA approval?

The first FDA approval for tirzepatide (as Mounjaro for type 2 diabetes) was in 2022. [1]
A later FDA approval expanded its use for obesity/weight management as Zepbound. [2]

How long has it been studied before it became a medicine?

Before approval in 2022, tirzepatide was in clinical development and trials; the FDA approvals came after the results from those studies supported its benefits and safety. [1][2]

Source notes on timelines

If you’re tracking “around” in the sense of clinical development versus market availability, clinical studies began years before the 2022 approvals. Market availability begins with the first FDA approval year (2022). [1][2]

Sources

[1] https://www.drugpatentwatch.com/patent/tirzepatide-mounjaro
[2] https://www.drugpatentwatch.com/patent/tirzepatide-zepbound